Cancer Biologics Market Size, Share & Growth Outlook to 2033
The global cancer biologics market is witnessing strong momentum as personalized therapies and immuno-oncology treatments reshape cancer care. With cancer cases rising worldwide and demand growing for targeted therapies, the market is set for remarkable expansion in the coming years.
Market Overview
The global cancer biologics market was valued at USD 122.49 billion in 2024 and is projected to grow from USD 130.7 billion in 2025 to reach USD 219.58 billion by 2033, registering a CAGR of 6.7% during the forecast period. Growth is being fueled by increasing regulatory approvals for biologic therapies and the shift toward precision medicine tailored to patients’ genetic and molecular profiles. Unlike conventional chemotherapy, cancer biologics target molecular pathways more precisely, leading to better outcomes with fewer side effects.
Cancer Biologics Market Growth Drivers
-
Rising cancer incidence: WHO estimates a 77% increase in new cancer cases by 2050, driving demand for advanced therapies.
-
Breast cancer burden: Globally, 1 in 12 women will face breast cancer in her lifetime, highlighting the need for innovative biologics.
-
Personalized medicine adoption: Therapies like trastuzumab (Herceptin) and pertuzumab (Perjeta) are enabling targeted treatments for HER2-positive breast cancer.
Market Restraints
One of the biggest challenges is cost. Biologic therapies can range from USD 10,000 to over USD 500,000 per year. For example, trastuzumab (Herceptin) costs nearly USD 50,000 for adjuvant therapy, while Zolgensma is priced at USD 2.1 million per treatment. These high costs limit accessibility and place a significant strain on healthcare systems.
Market Opportunities
Immuno-oncology is creating new possibilities. Breakthroughs like Keytruda (pembrolizumab) and CAR-T therapies are transforming outcomes. In 2023, the FDA approved Padcev plus Keytruda for bladder cancer, underscoring the potential of immuno-oncology in driving future market growth.
Regional Insights
-
North America: Leads the market with a CAGR of 6.9%, supported by advanced healthcare infrastructure, strong R&D, and reimbursement frameworks. The U.S. reported 1.96 million new cancer cases in 2023.
-
Asia-Pacific: Poised for the fastest growth at a CAGR of 7.1%, driven by India and China. India alone has 95 licensed biosimilars and over 40 more in development, making it a hub for affordable biologics.
-
Europe: A key market supported by EMA’s unified regulatory system. In 2023, more than 21 oncology drugs were approved, including Opdivo for pediatric melanoma.
Type Insights
-
Monoclonal Antibodies: Hold the largest share, with therapies like Herceptin, Rituxan, and Avastin leading due to their effectiveness in targeting cancer proteins.
-
Blood and Blood Products: Vital in managing side effects such as anemia and clotting disorders during chemotherapy.
-
Vaccines and Toxoids: An emerging category with potential for melanoma, prostate, and cervical cancer treatments.
Key Players
-
Hoffmann-La Roche Ltd
-
Novartis AG
-
Eli Lilly and Company
-
Sanofi
-
Celgene Corporation
-
Pfizer Inc.
-
Bayer AG
-
Johnson & Johnson Services Inc.
-
Bristol-Myers Squibb Company
-
Merck & Co. Inc.
-
Amgen Inc.
Recent Developments
-
Jan 2024: European Commission approved Roche’s Tecentriq SC, the first PD-L1 subcutaneous immunotherapy in the EU.
-
Feb 2024: FDA accepted priority review for Dupixent® in treating COPD with type 2 inflammation.
-
Mar 2024: Novartis released new data on Zolgensma showing sustained motor improvements in children with SMA.
Conclusion
The cancer biologics market is on a strong upward path, powered by innovation in immuno-oncology and the growing role of precision medicine. While high costs remain a hurdle, biosimilars and wider access in emerging markets are set to unlock significant opportunities in the years ahead.
About Us:
Straits Research is a leading global market intelligence and consulting firm, dedicated to delivering actionable insights and in-depth analysis across a wide range of industries. Our mission is to empower organizations, investors, and decision-makers with reliable data, strategic guidance, and forward-looking perspectives to help them thrive in a rapidly evolving business landscape.
Contact Us:
Email: sales@straitsresearch.com
Tel: +1 646 905 0080 (U.S.), +44 203 695 0070 (U.K.)
Website: https://straitsresearch.com/
Категории
Больше
In an increasingly digital world, the dental industry is embracing advanced technologies to streamline operations and improve patient care. One of the most transformative innovations reshaping dental practices today is artificial intelligence (AI). At the forefront of this change is Jaza, a cutting-edge technology company that offers a powerful AI Receptionist for Dentists in the USA. By...
The global Virtual Production Market Market is expected to reach USD 6.41 B Biliion by the end of 2030, with a valuation of USD 1.80 B Biliion in 2022, according to a report released by Zion Market Research. Over the course of the projected period, the market is anticipated to expand at a CAGR of 17.24%. The study examines the factors driving and limiting the global Virtual Production Market...
Book reliable airport transfers with SN Limo Service. We offer top limo service in Scituate, MA for Logan Airport rides and more. Luxury, on-time, stress-free travel. Luxury Airport Transportation by SN Limo Service Travel in comfort, style, and confidence with SN Limo Service, your trusted provider of premium airport limo service across the United States. Whether you're flying for...
"Executive Summary Ornamental Fish Market : Data Bridge Market Research analyses the global ornament fish market which was USD 5.76 million in 2022, is expected to reach USD 9.46 million by 2030 growing at a CAGR of 6.4% during the forecasted period of 2023 to 2030. The Ornamental Fish Market report encompasses thorough analysis of market with respect to several factors...
The term "It Girl" is often used in fashion and pop culture around the world. It describes a confident and stylish woman who stands out without even trying. She has a natural sense of fashion and knows how to carry any outfit. The It Girl is usually seen in trendy clothes, cool accessories, and effortless makeup. Many people follow her style choices and try to copy her looks. She often becomes...
